Dennis H. Langer, M.D., J.D.

Independent Director


Dr. Dennis H. Langer has served as a Director of several biotechnology, specialty pharmaceutical, and diagnostic companies, and has been CEO and/or co-founder of several healthcare companies. Previously, Dennis served as a Managing Partner of Phoenix IP Ventures, a private equity/venture capital firm specializing in life sciences. Prior to that, he was President, North America, of Dr. Reddy’s Laboratories. Dennis has also held several leadership positions at GlaxoSmithKline and its predecessor, SmithKline Beecham, including Senior Vice President of Research and Development. He was President and CEO of Neose Technologies, Inc., and also held R&D and marketing positions at Eli Lilly, Abbott and Searle. He began his career as a Chief Resident at Yale University School of Medicine, and held clinical fellowships at Harvard Medical School and the National Institutes of Health. He serves as a Director of Myriad Genetics, Inc., Dicerna Pharmaceuticals, Inc., Delcath Systems, Inc., and several private companies. He is a Clinical Professor in the Department of Psychiatry, Georgetown University School of Medicine.

Define the future at Braeburn...together.

Join Our Team